Mouse Anti-EBNA-1 Recombinant Antibody (clone 3D4) (CAT#: FAMAB-0523WJ)

This product is a mouse monoclonal antibody that is specific for EBV EBNA1. This antibody can be used in a variety of applications, such as ELISA, WB, IF.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
ELISA

Figure 1 Anti-EBNA-1 ELISA.

Figure 1 Anti-EBNA-1 ELISA.

3D4 was tested by ELISA, at increasing concentrations, for binding to EBNA-1, BSA, and the cystovirus, polymerase protein, P2 (negative control) coated on Costar plates. Plates were read at 405 nm at 20 minutes. 3D4 shows specificity for EBNA-1 under these conditions. Results are the averages of triplicates and standard deviations are indicated.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 2 3D4 was tested by ELISA for binding to dsDNA coated on Immulon-2 plates.

Figure 2 3D4 was tested by ELISA for binding to dsDNA coated on Immulon-2 plates.

Plates were read at 405 nm at 1 hour. Results in A and B are the average of triplicates and standard deviations are indicated.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 3 3D4 antibody is of the IgG1 isotype.

Figure 3 3D4 antibody is of the IgG1 isotype.

ELISA plates coated with unlabeled anti-IgG1, anti-IgG2a, anti-IgG2b, or anti-IgG3 were incubated with 1.5 µg/ml of 3D4 MAb followed by the respective polyclonal isotype specific antibodies conjugated to alkaline phosphatase.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

IF

Figure 4 Purified 3D4 at a concentration of 10 µg/ml was examined for binding to Crithidia luciliae slides.

Figure 4 Purified 3D4 at a concentration of 10 µg/ml was examined for binding to Crithidia luciliae slides.

Left panel shows the binding of 3D4 to kinetoplasts of Crithidia luciliae (arrow). Right panel; IgG1 isotype control antibody, does not bind specifically to kinetoplasts.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 5 3D4 adsorbed on dsDNA cellulose beads was completely depleted of antibody with reactivity for dsDNA and EBNA-1 as detected by ELISA.

Figure 5 3D4 adsorbed on dsDNA cellulose beads was completely depleted of antibody with reactivity for dsDNA and EBNA-1 as detected by ELISA.

Results represent OD 405 nm values after subtraction of non specific binding to cellulose only beads. Standard deviations of triplicate wells are indicated. Anti-dsDNA and anti-EBNA-1 ELISAs were performed on Immulon-2 and Costar plates respectively and ELISAs were developed when ODs on each plate reached maximal values.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 6 Post dsDNA cellulose adsorbed 3D4 shows reduced binding to EBNA-1 by Western blot.

Figure 6 Post dsDNA cellulose adsorbed 3D4 shows reduced binding to EBNA-1 by Western blot.

Left panel: Coomassie stained polyacrylamide gel. Right panel: Western blot: filters were immunostained with pre (lanes 2 and 3) or post dsDNA cellulose adsorbed 3D4 MAb (lane 4). Molecular weight markers used in Western blot were conjugated to strep-tag and were detected with Strep-Tactin-HRP.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 7 Binding of 3D4 to EBNA-1 is compared to that of 0211 by ELISA at two different concentrations of MAbs.

Figure 7 Binding of 3D4 to EBNA-1 is compared to that of 0211 by ELISA at two different concentrations of MAbs.

3D4 binds more strongly to EBNA-1 than 0211.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 8 Binding of 3D4 to several antigens is examined by ELISA.

Figure 8 Binding of 3D4 to several antigens is examined by ELISA.

3D4 does not show significant binding to other antigens tested.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 9 Binding of 0211 to several antigens is examined by ELISA.

Figure 9 Binding of 0211 to several antigens is examined by ELISA.

0211 binds moderately to Sm but not to the other antigens tested.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 10 3D4 binds to the carboxyl region while 0211 binds to both the carboxyl and amino regions of EBNA-1.

Figure 10 3D4 binds to the carboxyl region while 0211 binds to both the carboxyl and amino regions of EBNA-1.

(B) MAb 3D4 is strongly reactive with LS9 but not LS8 or LS7 as detected by ELISA. (C) MAb 0211 is reactive with LS7, LS8 and LS9 as detected by ELISA. Results in B and C are the average of triplicate wells.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 11 3D4 recognizes a 148 aa core domain in the carboxyl region of EBNA-1.

Figure 11 3D4 recognizes a 148 aa core domain in the carboxyl region of EBNA-1.

3D4 was tested by ELISA for binding to the 3 truncated fragments of EBNA-1. 3D4 binds strongly to all 3 fragments, the smallest being EBNA459-607.

Yadav, P., Tran, H., Ebegbe, R., Gottlieb, P., Wei, H., Lewis, R. H., ... & Spatz, L. (2011). Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One, 6(1), e14488.

ELISA

Figure 12 IgG antibody to EBNA‐1 cross‐reacts with dsDNA.

Figure 12 IgG antibody to EBNA‐1 cross‐reacts with dsDNA.

IgG MAb, 3D4 binds strongly to EBNA-1 (A) and cross-reacts with dsDNA (B) as determined by ELISA. ELISAs are representative of three experiments. ELISA values were obtained in triplicate. Error bars indicate standard deviations of triplicates.

Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.

ELISA

Figure 13 Comparison of the binding of 3D4 and 16D2 to EBNA‐1.

Figure 13 Comparison of the binding of 3D4 and 16D2 to EBNA‐1.

The binding of 16D2 and 3D4 to EBNA-1were compared by ELISA. Goat anti-mouse kappa-AP was used as secondary antibody to detect the binding of 16D2 (an IgM MAb) and 3D4 (an IgG MAb) in the same assay. Results represent the average of two experiments. Standard deviation is indicated by error bars.

Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.

ELISA

Figure 14 Peptide mapping. 3D4 was tested by ELISA for binding to peptides spanning the entire 148 amino acid VBS region.

Figure 14 Peptide mapping. 3D4 was tested by ELISA for binding to peptides spanning the entire 148 amino acid VBS region.

Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.

ELISA

Figure 15 3D4 was examined by ELISA for binding to GC‐15, GL‐15, and PFM‐15.

Figure 15 3D4 was examined by ELISA for binding to GC‐15, GL‐15, and PFM‐15.

3D4 was used at a concentration of 5 μg/ml for all above ELISAs. ELISAs are representative of two experiments. ELISA values were obtained in triplicate.

Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.

Inhib

Figure 16 Peptide inhibition of MAbs binding to EBNA‐1 and dsDNA.

Figure 16 Peptide inhibition of MAbs binding to EBNA‐1 and dsDNA.

3D4 (0.05 μg/ml) were incubated with increasing concentrations of peptides PFM-15 or GC-15 and examined by ELISA for binding to EBNA-1 (B). 3D4 (2.5 μg/ml) were incubated with increasing concentrations of peptides PFM-15 or GC-15 and examined by ELISA for binding dsDNA (D).

Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.

ELISA

Figure 17 MAbs that bind to the carboxyl region of EBNA‐1 but do not cross‐react with dsDNA, recognize a different epitope than the cross‐reactive antibodies.

Figure 17 MAbs that bind to the carboxyl region of EBNA‐1 but do not cross‐react with dsDNA, recognize a different epitope than the cross‐reactive antibodies.

(A) The IgG isotype of the non-cross-reactive MAbs 2F8, 14E10, 4F6, and 4B8 were determined by ELISA. (B) The non cross-reactive MAbs, were tested by ELISA at a range of concentrations, for binding to EBNA-1. 3D4 was used as the reference standard. MAbs were tested by ELISA for binding to dsDNA (C), to the amino and carboxyl regions of EBNA-1 (D) and to two truncated carboxyl fragments; aa 452-641 and aa 459-607 (E). MAb concentrations used were 12.5 μg/ml in (C) and 1.25 μg/ml in (D) and (E). ELISAs are representative of two experiments. ELISA values were obtained in triplicate. Error bars represent the standard deviations of triplicates.

Yadav, P., Carr, M. T., Yu, R., Mumbey‐Wafula, A., & Spatz, L. A. (2016). Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA. Immunity, inflammation and disease, 4(3), 362-375.


Specifications

  • Immunogen
  • rEBNA-1 in complete Freund's adjuvant
  • Host Species
  • Mouse
  • Derivation
  • Hybridoma
  • Type
  • Mouse IgG, κ
  • Specificity
  • EBV EBNA1
  • Species Reactivity
  • EBV
  • Clone
  • 3D4
  • Applications
  • ELISA, WB, IF
  • Related Disease
  • the autoimmune disease, Systemic Lupus Erythematosus (SLE)

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Epstein-Barr virus EBNA-1; EBNA-1

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "EBNA-1"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for FAMAB-0523WJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare